Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Kitcheetahon Apr 03, 2017 12:55pm

171 Views

Post# 26068695

Change of Auditors

there has been a change in auditors

"Theralase Technologies Inc. (the “Corporation”) hereby gives notice that Collins Barrow Toronto LLP (the “Former Auditor”) has resigned effective March 24, 2017 and that Marcum LLP (the “Successor Auditor”) has been appointed as the Corporation’s auditor effective March 24, 2017 until the next annual meeting of the Corporation."

found this in SEDAR data base.

Bullboard Posts

Thesis Gold makes high-grade discovery at Ring Zone